Bertrand Damour


Bertrand Damour has 20 years’ international management experience and a successful track record across the biotech industry in Europe and US. He was previously CEO at the US proteomics company GeneProt Inc.; Mind NRG, a Swiss biotech in the field of CNS (which was acquired by Minerva Neurosciences (NASDAQ: NERV); OncoEthix, a Swiss based oncolog...

Roles at NBE Therapeutics

  • CEO

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at NBE Therapeutics

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.